Covered recipient · General Payments record
ADAHLI MASSEY
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$4,522.73
- Reported across 196 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $866.06 | 31 |
| Consulting Fee | $810.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $1,115.11 | 5 |
| UCB, Inc. | $163.70 | 9 |
| Amgen Inc. | $84.24 | 5 |
| FIDIA PHARMA USA INC. | $76.98 | 1 |
| GENZYME CORPORATION | $58.00 | 3 |
| CARDINAL HEALTH INC | $42.84 | 1 |
| Acerta Pharma LLC | $30.59 | 2 |
| ABBVIE INC. | $20.48 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.34 | 1 |
| PFIZER INC. | $18.13 | 1 |
| Organon LLC | $16.76 | 1 |
| Mallinckrodt Hospital Products Inc. | $16.40 | 1 |
| Ferring Pharmaceuticals Inc. | $13.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.48 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103700722 | CMS |
| Amgen Inc. | $15.19 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111645729 | CMS |
| Amgen Inc. | $15.65 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111645731 | CMS |
| Amgen Inc. | $16.08 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111645733 | CMS |
| Amgen Inc. | $14.48 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111645735 | CMS |
| Amgen Inc. | $22.84 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111645727 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.95 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105505202 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.64 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104662017 | CMS |
| Cardinal Health Inc | $42.84 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100664330 | CMS |
| Ferring Pharmaceuticals Inc. | $13.49 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137475317 | CMS |
| Fidia Pharma USA Inc. | $76.98 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141157189 | CMS |
| GENZYME CORPORATION | $19.35 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139745534 | CMS |
| GENZYME CORPORATION | $17.75 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139745552 | CMS |
| GENZYME CORPORATION | $20.90 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139745574 | CMS |
| Janssen Biotech, Inc. | $80.56 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078253773 | CMS |
| Janssen Biotech, Inc. | $144.55 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078253819 | CMS |
| Janssen Biotech, Inc. | $60.00 | 12/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078253961 | CMS |
| Janssen Biotech, Inc. | $20.00 | 12/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078253965 | CMS |
| Janssen Biotech, Inc. | $810.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078254053 | CMS |
| Mallinckrodt Hospital Products Inc. | $16.40 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145069385 | CMS |
| Novartis Pharmaceuticals Corporation | $19.34 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086924959 | CMS |
| Organon Llc | $16.76 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136270902 | CMS |
| PFIZER INC. | $18.13 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130899433 | CMS |
| UCB, Inc. | $12.00 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488159 | CMS |
| UCB, Inc. | $32.73 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488165 | CMS |
| UCB, Inc. | $29.09 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488171 | CMS |
| UCB, Inc. | $11.91 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488177 | CMS |
| UCB, Inc. | $11.91 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488183 | CMS |
| UCB, Inc. | $10.20 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488191 | CMS |
| UCB, Inc. | $32.33 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488197 | CMS |
| UCB, Inc. | $4.20 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488204 | CMS |
| UCB, Inc. | $19.33 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488210 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.